Dune
Medical Devices was thrilled to host Congresswoman Lucy McBath in a
recent visit to their Alpharetta office. McBath is a member of the
United States House of Representatives from Georgia’s 6th congressional
district. Since joining Congress in January of this year, she has shown
support for multiple bills seeking to lower costs of healthcare for
patients and help advance medical innovation. This includes her
co-sponsorship of the bipartisan Protect Medical Innovation Bill (HR
2207) which would permanently repeal the 2.3% excise tax on medical
device sales revenue. Repealing this tax will, instead, allow those
dollars to be re-invested toward innovation and improving patient access
to important medical technologies. Dune Medical applauds McBath’s
leadership on these issues.
“It was fantastic getting to learn more about new and innovative
technologies that are being developed in our own backyard,”
Congresswoman McBath explained. “These technologies are important in
improving patient care and access.”
Dune Medical has developed MarginProbe®, a device that identifies
cancerous tissue in real-time during lumpectomy surgeries. Through their
proprietary RF spectroscopy technology, MarginProbe® indicates whether
there is any remaining cancer tissue on the removed breast specimen and
provides immediate feedback to the breast surgeon during the procedure,
allowing identified residual cancerous tissue to be removed during the
patient’s initial breast surgery.
Congresswoman McBath added, “As a two-time breast cancer survivor and
someone who has undergone two lumpectomies, I appreciated the
opportunity to meet with the Dune Medical team to learn more about
MarginProbe®.”
MarginProbe® is the only FDA approved device for identifying
positive margins during breast conservation surgery and has been
proven in approximately 20,000 cases, reducing re-excision rates up
to 79%.
“We were excited to show Congresswoman McBath the peace-of-mind that
MarginProbe® has provided to breast cancer patients,” explained Lori
Chmura, CEO of Dune Medical Devices. “As the representative for the
district where our office is headquartered and a two-time breast cancer
survivor herself, she understands the importance of medical innovation
and is an advocate for women’s healthcare. We are grateful for the
passionate support of Congresswoman McBath in helping to overcome
obstacles and improve access to care for unique solutions that lower
costs and improve patient outcomes.”
Dune Medical was also able to demonstrate future applications of the
technology, including Smart
Biopsy, with Congresswoman McBath. Dune Medical looks forward to
working with Congresswoman McBath in the future to help make innovative
technologies like MarginProbe® that aim to improve the current standard
of care available to every patient.
About Dune Medical Devices
“Imagine not having to wonder, did we get it all?”
At Dune Medical Devices, we believe in reducing the anxiety that waiting
for pathology results places on a patient and their families. Our
solutions, which are developed on a first-of-its-kind RF Spectroscopy
platform, can differentiate cancerous from healthy tissue based on
electromagnetic properties, making it possible for patients and
physicians to answer the question, “did we get it all?” For more
information, contact info@dunemedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190530005168/en/